BNP Paribas Financial Markets
AURA icon

BNP Paribas Financial Markets’s Aura Biosciences AURA Stock Holding History

BNP Paribas Financial Markets’s Portfolio AURA Stock Details AURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$755K Buy
106,351
+16,296
+18% +$117K ﹤0.01% 3508
2026
Q1 		$602K Sell
90,055
-24,554
-21% -$141K ﹤0.01% 3481
2025
Q4 		$625K Buy
114,609
+82,399
+256% +$489K ﹤0.01% 3449
2025
Q3 		$199K Buy
32,210
+18,711
+139% +$122K ﹤0.01% 4014
2025
Q2 		$84.5K Buy
13,499
+10,007
+287% +$58.5K ﹤0.01% 4072
2025
Q1 		$20.5K Sell
3,492
-2,602
-43% -$19.7K ﹤0.01% 4533
2024
Q4 		$50.1K Buy
+6,094
New +$57.4K ﹤0.01% 4432
2022
Q4 		– Sell
-5,821
Closed -$105K – 4091
2022
Q3 		$105K Buy
+5,821
New +$88.1K ﹤0.01% 3744

Other funds holding AURA

TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
LFCM
Long Focus Capital Management San Juan, Puerto Rico $3.91B AUM 12.68% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
CP
Caligan Partners New York $2.13B AUM 758.65% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
FIS
FCPM III Services Naarden, Netherlands $750M AUM 127.27% 1-Year Est. Return
MVM
Medicxi Ventures Management St. Helier, Jersey $177M AUM 212.06% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $3B AUM 119.43% 1-Year Est. Return

BNP Paribas Financial Markets's AURA Position: Q2 2026 in Review

BNP Paribas Financial Markets increased its Aura Biosciences (AURA) stake by 18% in Q2 2026, buying an estimated $117K and bringing the position to 106,351 shares worth $755K. The position accounts for ﹤0.01% of the portfolio, ranked #3508.

BNP Paribas Financial Markets first reported a position in AURA in Q3 2022 and has held it in 8 quarters since. 134 funds tracked by Wall St. Rank hold AURA as of Q2 2026.

  • BNP Paribas Financial Markets held 106,351 shares of Aura Biosciences worth $755K as of Q2 2026.
  • BNP Paribas Financial Markets bought 16,296 Aura Biosciences shares in Q2 2026, an estimated $117K.
  • Aura Biosciences made up ﹤0.01% of BNP Paribas Financial Markets's portfolio in Q2 2026, its #3508 holding.
  • BNP Paribas Financial Markets first reported a position in Aura Biosciences in Q3 2022 and has held it in 8 quarters since.
  • 134 funds tracked by Wall St. Rank held Aura Biosciences as of Q2 2026.

Based on BNP Paribas Financial Markets's 13F filing for Q2 2026, filed 13 Aug 2026.